Journal
RMD OPEN
Volume 9, Issue 1, Pages -Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/rmdopen-2022-002819
Keywords
Arthritis; Rheumatoid; Lupus Erythematosus; Systemic; Polymorphism; Genetic
Categories
Ask authors/readers for more resources
Japanese rheumatology and immunology have contributed to the advancement of rheumatology. The 67th Annual Scientific Meeting of the Japan College of Rheumatology, held in Fukuoka from April 24 to April 26, 2023, will discuss future perspectives such as precision medicine and genome-based drug discovery.
Japanese rheumatology and immunology have contributed to progress in the field and advancement of rheumatology, including postmarketing surveillance, development of IL-6-targeting therapy and concept of drug tapering, have accelerated in the 21st century. The 67th Annual Scientific Meeting of the Japan College of Rheumatology, held on Fukuoka on 24 April 2023-26 April 2023, will go ahead and beyond such an advancement. Profound discussion on future perspectives such as precision medicine, the elucidation of pathology and genome-based drug discovery by multilayered integration with various types of omics information, information on metabolome and proteome of blood metabolites, and database of target proteins and compounds for drug discovery will be discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available